mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
1 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |